Analogs of ghrelin substituted at the Nterminal

Details for Australian Patent Application No. 2007300526 (hide)

Owner Ipsen Pharma S.A.S.

Inventors Dong, Zheng Xin

Agent Griffith Hack

Pub. Number AU-B-2007300526

PCT Pub. Number WO2008/039415

Priority 60/847,423 27.09.06 US

Filing date 24 September 2007

Wipo publication date 3 April 2008

Acceptance publication date 21 July 2011

International Classifications

C07K 14/575 (2006.01) Peptides having more than 20 amino acids

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

Event Publications

14 May 2009 PCT application entered the National Phase

  PCT publication WO2008/039415 Priority application(s): WO2008/039415

2 July 2009 Alteration of Name

  The name of the applicant has been altered to Ipsen Pharma S.A.S. 2007305076 4LIFE RESEARCH, LC The name of the applicant has been altered to 4Life Research, LLC

21 July 2011 Application Accepted

  Published as AU-B-2007300526

17 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007300529-Acylated piperidine derivatives as melanocortin-4 receptor modulators

2007300525-Process for the preparation of 4-hydroxythieno[2,3-b]pyridine-5-carbo nitriles